Ticker Symbol: IGMS
IGM Biosciences Inc
$60.54 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
United States
Currency:
USD
Asset
Type: Common Stock
CIK:0001496323
Company Profile
Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 325 E Middlefield Rd
Website: igmbio.com
CEO: N/A
Tags:
- Health Technology
- Biotechnology
- Pharmaceuticals: Major
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $6.71
Change:
-$0.51
(
-7.06%)
Days Range: $6.64 - $7.37
Beta: 2.05
52wk. High: $28.20
52wk. Low: $4.09
Ytd. Change -64.62%
50 Day Moving Average: $6.46
200 Day Moving Average: $9.27
Shares Outstanding: 32865317
Valuation
Market Cap: 22.1B
PE Ratio: -1.27
EPS (TTM): -5.27
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A